Navigation Links
Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
Date:12/20/2007

s, caring for more than 17,000 patients annually. Recent quality performance analysis show that Kaiser Permanente and Group Health HIV patients have a very high rate of adhering to their medicine, strong viral control and good responses to therapy.

Co-authors on the study included Kaiser Permanente's Michael Silverberg, PhD, MPH, Leo Hurley, MPH, William Towner, MD, Daniel Klein, MD, Susan Bersoff-Matcha, MD, Winkler Weinberg, MD, Diana Antoniskis, MD, Miguel Mogyoros, MD, Robert Dobrinich, MD, Charles Quesenberry, PhD, and Drew Anthony Kovach, MD, and Wayne Dodge, MD, of Group Health.

About Kaiser Permanente

Kaiser Permanente is America's leading integrated health plan. Founded in 1945, it is a not-for-profit; group practice program headquartered in Oakland, Calif. Kaiser Permanente serves 8.7 million members in nine states and the District of Columbia. Today it encompasses the not-for-profit Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and their subsidiaries, and the for-profit Permanente Medical Groups. Nationwide, Kaiser Permanente includes approximately 156,000 technical, administrative and clerical employees and caregivers, and 13,000 physicians representing all specialties. For more information about Kaiser Permanente, visit the Kaiser Permanente News Center at: http://xnet.kp.org/newscenter

About the Kaiser Permanente Division of Research

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well being and to improve the quality and cost-effectiveness of health care. Currently, the center's 400-plus staff is working on more than 250 epidemiological and health services research projects.

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2008)...Survival Could be Extended if Patients Receive the...y ChemoFx, CHICAGO, May 20 /- Precis...moFx(R) Assay, a cell-based test that examines the... chemotherapies,correlates with significantly lon... ovarian cancer. Patients who received a treatment...
(Date:5/20/2008)...Newswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq:,... of its Niobe(R) Magnetic,Navigation System and Od...om key opinion leaders in electrophysiology at Hea...nual Scientific Sessions, which concluded on,Satur..., Dr. Xu Chen of the Rigshospitalet,-- Copenhagen ...
(Date:5/19/2008)...Newswire/ -- DDW 2008 Annual Meeting -- Ethicon,En...ts pivotal trial,demonstrated physician/nurse team... over sedation with propofol in patients undergoin...al cancer (colonoscopy), and disorders of,the uppe... will be,presented Tuesday at Digestive Disease We...
(Date:5/19/2008)...resented at the 2008 Annual European Congress of, ...nst Rheumatism (EULAR) -, - Initiation of Phase 1... 2008 -, SAN DIEGO...es, Inc.,(Nasdaq: RDEA ) today announced the iden...he treatment of patients with gout, RDEA594. Gout ...
Breaking Medicine Technology:Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 2Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 3Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 2Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 3Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 4Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 2Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 3Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 1423 1ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 1423 2Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 1Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 2Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 3LCA Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines Iowa 12574 1LCA Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines Iowa 12574 2Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 1Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 2Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 3
(Date:5/20/2008)...less than 5% trust magazines or advertising for,tr...-USNewswire/ -- The Physicians Coalition,for Injec...nd the health and,beauty community RealSelf.com ( ...of a joint survey reporting that 40% of consumers ...y 58% of consumers feel FDA approval,of an injecta...
(Date:5/20/2008)...ay 20 /PRNewswire-FirstCall/ -- Mercury Computer,S...of specialized,high-performance computing solutio...g applications, announced that management will pre...sday, May 29, 2008 at the Cowen and,Company 20/20 ...e will be,held at the New York Palace Hotel, in Ne...
(Date:5/20/2008)...ped approaches to designing a preventive HIV vacci...us Diseases (NIAID), part of the National Institut... the study of B cells, immune cells that can produ... The $15.6 million, five-year program will strengt...ccine research through a network of 10 research te...
(Date:5/20/2008)...ay 20 /PRNewswire/ -- New research that delivers,i...d competitive,intelligence data gathering for the ...ice Database, an online research repository manage...LLC., To review sample key findings and key metri...ks to each study at this address:, http://www3.bes...
Breaking Medicine News(10 mins):Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 2Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 3Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 4Health News:Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008 2Health News:NIAID to advance B-cell approach to HIV vaccines 2Health News:NIAID to advance B-cell approach to HIV vaccines 3Health News:Best Practice Database Adds Research on Merger Integration and Competitive Intelligence 2
...have denounced as insensitive National Institute ...ion for restricted use of Lucentis (ranibizumab) a...d people will be condemned to blindness each year ...ecision is implemented, they contended. Both Luc...
...ctor, with expertise in anesthetics and obstetrics...oner too? You can then make a beeline for Temor... Its mayor Peter Speirs is offering you half a mi...that if the town doesn't get a suitable person, ex...
...at the University of Pittsburgh School of Medicine...y have significant implications for the treatment ... from muscle-derived stem cells (MDSCs) and a biod...bit extensive remodelling, and remain free of bloc...
...e all inhibitions to maintain a contact with peopl...e), a charitable trust, is running a restaurant th...ts here. Managed by HIV+ individuals, Aadhar has ...t as community kitchen outlet since January (2007)...
Other Medicine News:Health News:UK Suggestion for Restricted Use of Anti-AMD Drugs Draws Flak 2Health News:UK Suggestion for Restricted Use of Anti-AMD Drugs Draws Flak 3Health News:Half a Million Dollars Offered for GPs With Expertise in Anesthetics and Obstetrics 2Health News:Scientists Develop Artificial Blood Vessels for Vascular Grafts in Mice 2Health News:An Exclusive Restaurant to Appease the Culinary Needs of HIV/AIDS Patients 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: